Spegra Tablets

Spegra Tablets

Spegra Tablets is a combination antiretroviral medication used for the treatment of HIV-1 infection. It contains tenofovir disoproxil fumarate, lamivudine, and dolutegravir, which work together to suppress viral replication and improve immune system function. This once-daily regimen is commonly used as a first-line therapy in HIV management due to its effectiveness and convenience. It helps reduce viral load to undetectable levels when taken consistently. In treatment plans, alternatives such as Inbec Tablets – Triumeq and Emletra Tablets – Generic Kaletra may also be considered based on patient-specific factors.

Mechanism of Action

Triple Antiviral Action

• Dolutegravir inhibits the integrase enzyme, blocking viral DNA integration
• Tenofovir inhibits reverse transcriptase, reducing viral replication
• Lamivudine also inhibits reverse transcriptase

Effective Viral Control

This combination targets multiple stages of the HIV life cycle, helping achieve strong and sustained viral suppression. For clinical insights, refer to World Health Organization (WHO) and for safety guidance, consult Mayo Clinic – HIV Treatment Information.

Medical Uses

Spegra Tablets is used for:

• HIV-1 infection treatment
• Viral load suppression
• First-line antiretroviral therapy (ART)
• Long-term HIV management

It is widely recommended in modern HIV treatment guidelines.

Dosage and Administration

Spegra Tablets are taken orally once daily, with or without food, as prescribed by a healthcare provider. Consistent daily use is essential for maintaining viral suppression and preventing resistance. In clinical practice, Inbec Tablets – Triumeq and Emletra Tablets – Generic Kaletra may be used as alternative regimens.

Clinical Effectiveness

Clinical studies show that dolutegravir-based combinations like Spegra provide rapid viral suppression, improved immune function, and high treatment success rates when taken regularly.

Safety and Side Effects

Common Side Effects

• Headache
• Nausea
• Insomnia
• Fatigue

Serious Risks

• Kidney problems (due to tenofovir)
• Liver dysfunction
• Lactic acidosis (rare)

Regular monitoring of kidney and liver function is recommended. For more details, refer to Mayo Clinic – HIV Treatment Information.

Contraindications and Precautions

Spegra Tablets should be used with caution in:

• Patients with kidney disease
• Individuals with liver disorders
• Pregnant or breastfeeding women

Medical supervision is required.

Drug Interactions

Spegra may interact with antacids, supplements, and other medications affecting kidney function. Patients should inform their healthcare provider about all medicines they are taking. For further reading, refer to World Health Organization (WHO).